CIK 0000730272 · Large accelerated filer
REPLIGEN CORP
Sign in to watch- Ticker
- RGEN
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 042729386
- Phone
- 7814499560
- Business address
- 41 SEYON STREET, BUILDING 1, SUITE 100, WALTHAM, MA, 02453
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,953,260
- in 5 filings, $6.0M under 10b5-1 plans
Net −$5,953,260. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-11-13 | Hunt Anthony Director | Sale | −3,000 | $155.45 | $466K | 88,436 |
| 2025-11-13 | Hunt Anthony Director | Sale | −5,737 | $156.22 | $896K | 82,699 |
| 2025-11-13 | Hunt Anthony Director | Sale | −1,956 | $157.11 | $307K | 80,743 |
| 2025-11-13 | Hunt Anthony Director | Option exercise | +2,952 | $33.87 | $100K | 83,695 |
| 2025-11-13 | Hunt Anthony Director | Option exercise · Stock Option (Right to Buy) | +2,952 | 14,760 | ||
| 2025-11-12 | Hunt Anthony Director | Option exercise 10b5-1 | +25,000 | $33.87 | $847K | 125,743 |
| 2025-11-12 | Hunt Anthony Director | Sale 10b5-1 | −3,741 | $154.92 | $580K | 122,002 |
| 2025-11-12 | Hunt Anthony Director | Sale 10b5-1 | −4,740 | $155.85 | $739K | 117,262 |
| 2025-11-12 | Hunt Anthony Director | Sale 10b5-1 | −4,959 | $156.65 | $777K | 112,303 |
| 2025-11-12 | Hunt Anthony Director | Sale 10b5-1 | −11,096 | $158.01 | $1.8M | 101,207 |
| 2025-11-12 | Hunt Anthony Director | Sale 10b5-1 | −464 | $158.51 | $74K | 100,743 |
| 2025-11-12 | Hunt Anthony Director | Option exercise · Stock Option (Right to Buy) 10b5-1 | −25,000 | 157,344 | ||
| 2025-10-02 | Loeillot Olivier Chief Executive Officer | Shares withheld for taxes | −1,248 | $145.23 | $181K | 42,939 |
| 2025-09-25 | Garland Jason K CFO | Shares withheld for taxes | −412 | $121.68 | $50K | 13,383 |
| 2025-09-10 | Hunt Anthony Director | Option exercise | +20,000 | $33.87 | $677K | 129,854 |
| 2025-09-10 | Hunt Anthony Director | Sale | −96 | $116.34 | $11K | 129,758 |
| 2025-09-10 | Hunt Anthony Director | Sale | −1,108 | $118.32 | $131K | 128,650 |
| 2025-09-10 | Hunt Anthony Director | Sale | −3,262 | $119.64 | $390K | 125,388 |
| 2025-09-10 | Hunt Anthony Director | Sale | −14,882 | $120.19 | $1.8M | 110,506 |
| 2025-09-10 | Hunt Anthony Director | Sale | −7,584 | $121.42 | $921K | 102,922 |
Page 5 of 11 · 215 trades